Shenzhen Salubris Pharmaceuticals (002294.SZ) has submitted an application to the Hong Kong Stock Exchange for the issuance and listing of H-shares.

date
08:00 13/02/2026
avatar
GMT Eight
Sinopharm (002294.SZ) announced that on February 12, 2026, the company submitted an application to the Hong Kong Stock Exchange to issue H shares and list on the main board of the Hong Kong Stock Exchange. On the same day, the application materials for this issuance and listing were published on the Hong Kong Stock Exchange website.
Shenzhen Salubris Pharmaceuticals (002294.SZ) announced that on February 12, 2026, the company submitted an application to issue H shares and list on the main board of The Stock Exchange of Hong Kong Limited. The application materials for this issuance and listing were posted on The Stock Exchange of Hong Kong Limited website on the same day.